Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
Dotmatics Supports Umicore Corporate R&D in Processing of Experimental Data
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it […]
Dotmatics Biology Solution for Antibody Discovery Streamlines Data Collection and Workflows to Accelerate Antibody Research and Therapies
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer
Insightful Science, the world’s most widely adopted software platform for scientific R&D and collaboration, today announced […]
Dotmatics Partners with RockStep Solutions to Provide an Integrated Solution for Digitalized in Vivo Drug Discovery
Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more